• Interim guidance for the investigation and management of outbreaks and incidents of unusual illness



• Nerve agents: Key points



• Nerve agents: Guidelines for action in the event of a deliberate release



• General information - Tularemia



• Interim guidelines for action in the event of a (suspected) deliberate release of tularemia



• How to spot a deliberate release: Clinical tips and cardinal signs



• General information - Botulism



• Interim guidelines for action in the event of a deliberate release of botulism



• General information - Viral hemorrhagic fevers



• Interim guidelines for action in the event of a deliberate release of viral haemorrhagic fevers



• Bioterrorism.com



• Web Site Helps Doctors And Nurses Diagnose Bioterrorist Agents



• Free Continuing Education Credits In Bioterrorism Preparedness To Clinicians Courtesy Of University Of Alabama, Birmingham



• Guide for All-Hazard Emergency Operations Planning



• The Public Health Response To Biological And Chemical Terrorism



• Information For Patients: Resources To Help With The Mental Response To Terrorist Acts Against America



• Bioterrorism Readiness Plan: A Template For Healthcare Facilities



• Biological And Chemical Terrorism: Strategic Plan For Preparedness And Response Recommendations



• Bioterrorism And Anthrax



• Bioterrorism And Botulism



• Bioterrorism And Yersinia Pestis (Plague)



• Bioterrorism And Variola Major (Smallpox)



• Health Information For First Responders - Mustard Gas



• FEMA - Coordinating Preparedness And Response



• WHO Draft Statement: Health Aspects Of Biological And Chemical Weapons



• An Antidote To Anthrax?



• The Plague, De-Coded



• JAMA Articles Available On Biological Weapons



• Work Called Key Influence On Mental Health After Attacks



• US Anthrax Scare



• Information For Patients: Anthrax



• Questions And Answers About Anthrax Prevention And Treatment



• Industry Expert: "Printed Page Great For Transmitting Information--Not Anthrax"



• How To Handle Anthrax Threats



• After A Disaster: A Guide For Parents And Teachers



• Questions And Answers: Anthrax Vaccine - Civilian Inquiries



• FDA Public Health Advisory: Update On Use Of Doxycycline For Anthrax Exposure



• CDC Urges Physicians To Watch For Bioterrorism Outbreaks Following Anthrax Mailings



• From The MMWR: Investigation of Anthrax Associated with Intentional Exposure and Interim Public Health Guidelines, October 2001



• Recognition Of Illness Associated With The Intentional Release Of A Biologic Agent



• Facts About Anthrax Argue For Greater Calm



• Law Enfocement Officials, FBI, Skeptical Of Link Between Anthrax Cases And Terrorists



• Prescribing Information: Cipro (Ciprofloxacin)



• Information For Health Professionals: Indications For Cipro http://www.vidyya.com/today/v3i198_2.htm



• Information For Health Professionals: Cipro Dosing Chart



• FDA Approved Ciprofloxacin For Victims Of Anthrax Inhalation In August, 2000



• Bayer Confirms Cipro Talks With HHS And Reaffirms Offer Of Donation Of 2 MM Cipro Tablets For Emergency Responders



• Update On Use Of Doxycycline For Anthrax Exposure



• Information For Professionals: Protecting Investigators From Exposure To Bacillus Anthracis Using Personal Protective Equipment



• Researchers Discover Secrets Of Anthrax's Killer Toxin



• Strengthening National Preparedness For Smallpox: An Update



• The CDC's Interim Recommendations For The Selection And Use Of Protective Clothing And Respirators Against Biological Agents



• MMWR Update: Investigation Of Bioterrorism-Related Anthrax And Interim Guidelines For Exposure Management And Antimicrobial Therapy, October 2001



• Information For Patients: FAQs About Smallpox



• JAMA Reprint: Consensus Statement - Smallpox As A Biological Weapon Medical And Public



• Kaiser Permanente Issues Anthrax Clinical Guidelines Update For Physicians And Nurses



• Updated Recommendations For Handling Suspicious Packages Or Envelopes



• Anthrax Vaccine May Be Given To High-Risk Workers



• Clinical Anthrax - Information From The CDC



• Lax Regulations A Problem: Access To Disease Cultures Makes Labs Terrorist Targets



• Doxycycline, The New/Old Drug Of Choice Against Anthrax



• FDA Encourages Drug Firms To Revise Doxycycline And Penicillin G Procaine Labeling With Information For Treating Inhalational Anthrax (Post-Exposure)



• Anthrax, Made In The USA



• From The FDA: Cipro (Ciprofloxacin) Use by Pregnant and Lactating Women



• Information For Patients: Q & A For Consumers On Doxycycline



• Physician Guidelines for Evaluation of Possible Anthrax Disease



• Doxycycline (Vibramycin, Monodox, Doryx, Doxy, Atridox, Periodox, Vibra-Tabs) Use By Pregnant And Lactating Women



• Investigation Of Bioterrorism-Related Anthrax And Interim Guidelines For Clinical Evaluation Of Persons With Possible Anthrax



• Scientists In India Have Created A New Vaccine For Anthrax



• New Rapid Anthrax Test Developed Through Collaboration



• Q & A: Influenza (Flu) And Anthrax



• Bioterrorism-Related Inhalational Anthrax: The First 10 Cases Reported In The United States



• Anthrax Findings Presented by NIH Researcher



• Update: Investigation Of Bioterrorism-Related Anthrax 2001



• Disaster Readiness: Resources Guidance For Health Professionals



• CDC Update: Investigation Of Bioterrorism-Related Inhalational Anthrax -- Connecticut, 2001



• CDC Update: Adverse Events Associated With Anthrax Prophylaxis Among Postal Employees --- New Jersey, New York City, And The District Of Columbia Metropolitan Area, 2001



• MMWR Notice to Readers: Additional Options for Preventive Treatment for Persons Exposed to Inhalational Anthrax



• Clinical And Epidemiologic Principles Of Anthrax



• Information For Patients - What You Need To Know About Offers To Treat Biological Threats



• CDC Releases New Bioterrorism Web Resources For Clinicians, Lab Professionals, Public



• US Identifies Most Dangerous Biological Agents



• Training Of Clinicians For Public Health Events Relevant To Bioterrorism Preparedness



• Expanded Web Site Will Help Primary Care Physicians Diagnose Smallpox, Anthrax, And Other Bioterrorism-Related Infections



• Anthrax Information From The Control Of Communicable Diseases Manual



• Los Angeles County: Bioterrorism Syndromes Poster



• Information For The General Public: Guidance On Anthrax



• Fact Sheet: Anthrax



• Clinical Study: Plasmapheresis Of Anthrax-Vaccinated Subjects For Production Of Anthrax Immune Globulin



• HHS Issues Guidelines For Safeguarding Building Ventilation Systems From Terrorist Attacks



• CDC Poster: Evaluating Patients For Smallpox



• Detection Of Bioterrorism Viruses Brought Closer To Local Sites
  
  
• Bioterrorism Readiness Plan: A Template For Healthcare Facilities
  
  
• Bioterrorism Readiness Planning Guidance For State Public Health Officials
  
  
• Information Technology Can Help Clinicians Respond To Bioterrorism Events
  
  
• Summary Evidence Report/Technology Assessment: Bioterrorism Preparedness and Response: Use of Information Technologies and Decision Support Systems
  
  
• National Institute Of Environmental Health Sciences Public Health Report Stresses Worker Protection As Key Component Of Homeland Security
  
  
• Learning From Disasters: Weapons Of Mass Destruction Preparedness Through Worker Training
  
  
• Bioterrorism Emergency Planning And Preparedness Questionnaire For Healthcare Facilities
  
  
• AHRQ Unveils Hospital Bioterrorism Preparedness Tool
  
  
• Bioterrorism Training Is Focus of HHS Partnership
  
  
• WHO’s response to the threat of deliberate releases of chemical and biological agents
  
  
• Disaster Assessment: A UN Training Module
  
  
• Global public health response to natural occurrence, accidental release or deliberate use of biological and chemical agents or radionuclear material that affect health
  
  
• Anti-anthrax drug overuse sparks fears
  
  
• Guidance for protecting building environments from airborne chemical, biological, or radiological attacks
  
  
• CDC sees no evidence of bioterrorism in spread of West Nile virus
  
  
• Survey on eve of anthrax attacks showed need for bioterrorism training: HHS agencies working with partners on broad training initiative
  
  
• States need way to track victims of terrorist attacks
  
  
• Interim guidelines for action in the event of a deliberate release of viral haemorrhagic fevers
  
  
• General information - Viral hemorrhagic fevers
  
  
• Interim guidelines for action in the event of a deliberate release of botulism
  
  
• General information - Botulism
  
  
• How to spot a deliberate release: Clinical tips and cardinal signs
  
  
• Interim guidelines for action in the event of a (suspected) deliberate release of tularemia
  
  
• General information - tularemia
  
  
• Nerve agents: Guidelines for action in the event of a deliberate release
  
  
• Nerve agents key points
  
  
• Interim guidance for the investigation and management of outbreaks and incidents of unusual illness
  
  
• Interim Guidelines for Action in the Event of a Deliberate Release of anthrax
  
  
• General information - Anthrax
  
  
• Questions commonly asked by health care providers
  
  
• Clinical evaluation and management of persons with possible cutaneous anthrax
  
  
• Clinical evaluation and management of persons with possible inhalation anthrax
  
  
• Laboratory security and emergency response guidance for laboratories working with select agents
  
  
• Information for patients: What is ricin? (A highly toxic poison that is linked to terrorist activity)
  
  
• Information for clinicians: Smallpox vaccination and adverse reactions
  
  
• Risk for a biological weapons attack is increasing
  
  
• Bioterrorism watch: Q & A - NIH's building 470 in Frederick, Maryland
  
  
• US prepares soldiers for Iraq's chemical and biological weapons
  
  
• Talking to children about war and terrorism
  
  
• HHS to test use of handheld device network for transmitting urgent information about biological agents to clinicians
  
  
• UK: Ability to cope with biological or chemical attack endangered by changes to the Public Health Laboratory Service (PHLS)
  
  
• FDA issues new security guidance as part of Operation Liberty Shield to protect the food supply
  
  
• Too few doctors know how to respond to a terrorist attack
  
  
• Are you ready? A guide to citizen preparedness
  
  
• Information for parents: How to prepare emergency dosages of doxycycline at home for infants and children (From the U.S. FDA)
  
  
• Planning against biological terrorism: Lessons from outbreak investigations
  
  
• Summary on the Laboratory Response Network (LRN) - LRN current capacity
  
  
• New model helps hospitals and health systems better respond to potential bioterrorism
  
  
• The it-can't-happen-here response to bioterrorism
  
  
• FDA approves first new drug application for treatment of radiation contamination due to cesium or thallium
  
  
• Investigation of a ricin-containing envelope at a postal facility --- South Carolina, 2003
  
  
• Vidyya bioterrorism page: Frequently asked questions about a nuclear blast
  
  

  Return to Vidyya home

  Return to the ExLibris Collection